Neuroone Medical Technologies NMTC Cash Flow Statement (2010-2026)

NASDAQ NMTC
$1.66 -0.03 (-1.78%)
At close: Sep 9, 2026 · 4:00 PM EDT
Reported Financials

Neuroone Medical Technologies Quarterly Cash Flow Statement

Periods 62 quarters
Latest Jun 2026

Neuroone Medical Technologies reported cash from operations of -$1.08M and free cash flow of -$1.10M for the quarter ended Jun 2026, up 26.1% year over year. This cash flow statement covers 62 quarters of results from Sep 2010 through Jun 2026, standardized by Business Quant from the company’s SEC filings.

Cash Flow Statement Sep2010 Dec2010 Mar2011 Jun2011 Sep2011 Dec2011 Mar2012 Jun2012 Sep2012 Dec2012 Mar2013 Jun2013 Sep2013 Dec2013 Mar2014 Jun2014 Mar2015 Jun2015 Sep2015 Dec2015 Mar2016 Jun2016 Sep2016 Dec2016 Mar2017 Jun2017 Sep2017 Dec2017 Mar2018 Jun2018 Sep2018 Dec2018 Mar2019 Jun2019 Sep2019 Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026
Operating Activities
Net Income
-2.64M-2.81M-3.06M-2.76M-1.37M-1.73M-3.52M-3.47M-3.14M-3.34M-2.86M-2.77M-3.35M1.79M-2.27M-1.50M-1.62M-1.44M-2.38M-2.01M
Share-based CompensationStock Comp.
0.34M0.20M0.23M0.26M0.26M0.30M0.24M0.30M0.27M2.81M2.88M2.81M0.34M2.81M2.87M6.13M0.36M6.09M1.10M1.13M
Gains from Investment SecuritiesGains Investment
-0.39M-0.39M-0.32M0.31M-0.22M0.01M-0.41M
Asset Writedowns and ImpairmentWritedown
0.00M
Cash from OperationsCash from Ops.
-2.03M-2.68M-3.22M-2.64M1.02M-3.49M-3.55M-2.94M-2.90M-3.81M-2.18M-2.36M-2.67M0.21M-0.06M-1.46M-1.53M-3.12M-1.33M-1.08M
Depreciation, Depletion & Amortization
Amortizatization of IntangiblesAmort. of Intangibles
0.02M0.02M0.00M
Amortization of Deferred ChargesAmort. Deferred Charges
0.19M
Depreciation & Amortization (CF)Dep. & Amort.
0.02M0.03M0.03M0.03M0.03M0.04M0.04M0.06M0.06M0.06M0.06M0.06M0.06M0.07M0.07M0.07M0.06M0.07M0.06M0.05M
Change in Working Capital
Change in ReceivablesChange Receivables
0.01M-0.02M0.01M-0.04M0.03M0.06M0.12M-0.21M0.54M0.01M-0.15M-0.23M2.19M-2.05M-0.32M1.26M1.40M-0.76M-0.80M
Change in InventoryChange Inventory
0.05M0.13M-0.01M0.23M0.25M0.20M0.27M0.34M0.21M-0.12M-0.30M0.48M0.84M-0.70M-0.10M0.07M0.33M-0.56M0.43M0.19M
Change in Account PayablesChange Payables
0.12M0.29M-0.26M-0.12M0.60M-0.15M0.13M-0.04M-0.18M0.08M-0.00M-0.03M0.02M-0.01M0.10M-0.37M0.53M-0.44M0.38M-0.03M
Change in Accured ExpensesChange Accured Exp.
0.13M-0.32M-0.02M0.11M1.66M-0.31M-1.36M0.16M0.28M-0.52M0.10M0.20M0.24M-0.46M0.03M0.07M0.30M-0.62M0.03M0.36M
Investing Activities
Capital ExpendituresCapex
0.04M0.06M0.09M0.05M0.07M0.01M0.18M0.14M0.06M0.04M0.03M0.01M0.04M0.02M0.00M0.04M0.01M0.04M0.04M0.02M
Change in Acquisitions & DivestmentsChange Acquisitions
1.50M2.00M1.00M
Cash from Investing ActivitiesCash from Investing
-0.04M-0.06M-0.09M-0.05M-3.04M0.02M1.82M0.86M-0.05M-0.04M-0.03M-0.01M-0.04M-0.02M-0.00M-0.04M-0.01M-0.04M-0.04M-0.02M
Financing Activities
Other financing activitiesOther financing
1.26M2.09M0.17M-1.00
Cash from Financing ActivitiesCash from Financing
-0.02M12.02M-322.00-0.02M0.66M1.56M5.19M1.21M1.96M1.56M2.54M-0.51M0.25M8.23M0.07M0.15M0.61M0.35M
Change in Capital Stock
Net Shares Issued and RepurchasedNet Shares Issued
0.15M0.07M0.06M0.34M0.47M1.16M0.07M1.23M0.01M0.55M3.34M0.00M0.08M0.03M
Net Equity Issued and RepurchasedNet Equity Issued
-1.33M0.52M1.62M1.26M2.09M1.68M-4.20M9.20M0.36M
Additional items
Change in Cash
-2.09M9.28M-3.32M-2.69M-2.02M-3.49M-1.07M-0.52M2.24M-2.64M-0.25M-0.81M-0.16M-0.33M0.19M6.72M-1.47M-3.01M-0.76M-0.76M
Free Cash FlowFCF
-2.06M-2.74M-3.31M-2.69M0.95M-3.50M-3.73M-3.08M-2.96M-3.85M-2.21M-2.38M-2.70M0.18M-0.06M-1.51M-1.54M-3.16M-1.37M-1.10M
Net Cash FlowNCF
-2.09M9.28M-3.32M-2.69M-2.02M-3.49M-1.07M-0.52M2.24M-2.64M-0.25M-0.81M-0.16M-0.33M0.19M6.72M-1.47M-3.01M-0.76M-0.76M